[Therapeutic dilemmas in patients with a centrally-located pulmonary embolism confirmed by spiral CT-scan but with no cardiogenic shock].
3 patients, 2 women aged 64 and 44 and 1 man aged 67, had severe dyspnoea and a large centrally-located pulmonary embolism (PE) without any accompanying arterial hypotension. They were all given conventional anticoagulation therapy, although thrombolytic therapy was also considered. The women recovered but the man eventually died of a second massive embolism. PE is a disease with a potentially high mortality. Patients with cardiogenic shock due to PE are candidates for thrombolytic therapy. A subset of patients with right-ventricular dysfunction (submassive PE) also have a poorer prognosis despite the absence ofarterial hypotension or shock. Spiral CT-scan is becoming the first-line imaging test of preference in patients with suspected PE. Spiral CT enables the accurate visualization ofthrombi. The value of risk management using cardial biomarkers, spiral CT and echocardiography is not yet clear. There is no evidence that thrombolytic therapy is beneficial in patients with acute PE and right-ventricular dysfunction without overt shock.
Kamphuisen
P W
PW
Universitair Medisch Centrum St Radboud, Nijmegen. kamphuisen.botermans@planet.nl
Heijdra
Y F
YF
van Die
C E
CE
van Dijk
A P
AP
Bredie
S J H
SJ
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D004452:Echocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D012770:Shock, Cardiogenic / Q000209:etiology; D015912:Thrombolytic Therapy; D036542:Tomography, Spiral Computed; D016896:Treatment Outcome; D018497:Ventricular Dysfunction, Right / Q000209:etiology
D000925:Anticoagulants; D005343:Fibrinolytic Agents